🇺🇸 FDA
Patent

US 11872203

Methods of administering solriamfetol to lactating women

granted A61KA61K31/165A61K31/27

Quick answer

US patent 11872203 (Methods of administering solriamfetol to lactating women) held by AXSOME MALTA LTD. expires Mon Jan 11 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
AXSOME MALTA LTD.
Grant date
Tue Jan 16 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 11 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K31/165, A61K31/27, A61K9/0053